PositiveID (PSID) Stock Price, News & Analysis

Company Overview

PositiveID Corp (OTCMKTS:PSID) is a life sciences company specializing in the development and commercialization of molecular diagnostic assays, detection platforms and health information technology solutions. The company’s molecular diagnostics business is focused on creating point-of-care tests for the rapid and accurate identification of infectious pathogens, environmental contaminants and chemical agents. These offerings leverage immunoassay and biosensor technologies to support applications in healthcare, public health and industrial testing environments.

In its health information technology segment, PositiveID offers software and mobile solutions aimed at real-time electronic disease surveillance, laboratory reporting and outbreak management. The company’s platforms are designed to facilitate secure data exchange and analytics for public health agencies and healthcare providers, supporting efforts to accelerate case reporting and improve situational awareness during epidemics. Integrations encompass electronic laboratory reporting interfaces and mobile delivery to state and local health jurisdictions.

Founded in 1999 and headquartered in Austin, Texas, PositiveID serves public health agencies, hospitals and diagnostic laboratories across North America. The company holds a portfolio of patents and proprietary technologies, and its management team brings expertise in molecular diagnostics, digital health and regulatory affairs. PositiveID continues to pursue strategic collaborations and product development initiatives to address emerging public health challenges and expand its diagnostic and digital health offerings.

Key Stats

• Today's Range: $0.0001 to $0.0002
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0002
• Volume: 32.70 million shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PSID Stock Analysis - Frequently Asked Questions

How have PSID shares performed this year?

PositiveID's stock was trading at $0.0001 at the beginning of 2025. Since then, PSID stock has increased by 0.0% and is now trading at $0.0001.

How do I buy shares of PositiveID?

Shares of PSID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PositiveID own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PositiveID investors own include Vuzix (VUZI), Marijuana Company of America (MCOA), Bridgeline Digital (BLIN), InterCloud Systems (ICLD), XTI Aerospace (XTIA), DICK'S Sporting Goods (DKS) and Precipio (PRPO).

Company Calendar

• Today: 9/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:PSID
• CIK: 1347022
• Web: www.psidcorp.com
• Phone: 561-805-8000
• Fax: 561-805-8001
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A